94 related articles for article (PubMed ID: 6525604)
21. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of pyrazofurin in advanced head and neck cancer.
Cheng E; Currie V; Wittes RE
Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
[No Abstract] [Full Text] [Related]
23. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
[No Abstract] [Full Text] [Related]
24. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
25. Phase II trials of methylglyoxal-bis (guanylhydrazone).
Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW
Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
[No Abstract] [Full Text] [Related]
27. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
Yap HY; Blumenschein GR; Schell F; Bodey GP
Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.
Shah MK; Engstrom PF; Catalano RB; Paul AR; Bellet RE; Creech RH
Cancer Treat Rep; 1982 Mar; 66(3):557-8. PubMed ID: 7060043
[No Abstract] [Full Text] [Related]
29. Phase II evaluation of maytansine in patients with advanced head and neck cancer.
Creagan ET; Fleming TR; Edmonson JH; Ingle JN
Cancer Treat Rep; 1979; 63(11-12):2061-2. PubMed ID: 526939
[No Abstract] [Full Text] [Related]
30. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
[No Abstract] [Full Text] [Related]
31. Severe neurotoxicity with methyl G: CALGB experience.
Spaulding MB; Barron SS; Comis RL; Richards F; Kennedy BJ; Pajak TF
Med Pediatr Oncol; 1982; 10(5):521-4. PubMed ID: 6292681
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Benner SE; Lippman SM; Huber MH; Hong WK
Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung.
Samson MK; Baker LH; Cummings G; Talley RW
Am J Clin Oncol; 1982 Dec; 5(6):631-3. PubMed ID: 7165005
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
[No Abstract] [Full Text] [Related]
35. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
Moore MR; Graham SD; Birch R; Irwin L
Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
[No Abstract] [Full Text] [Related]
36. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF
Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859
[TBL] [Abstract][Full Text] [Related]
37. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
Hart RD; Ohnuma T; Holland JF; Bruckner H
Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
Witherspoon RP; Legha SS; Reimer RR; Talley RW; Stuckey WJ; Dixon DO; McCracken JD; Stephens RL; Oishi N
Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
[No Abstract] [Full Text] [Related]
39. Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.
Creagan ET; Schutt AJ; Ingle JN; O'Fallon JR
Cancer Treat Rep; 1983 Nov; 67(11):1047. PubMed ID: 6640554
[No Abstract] [Full Text] [Related]
40. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
